HBM Partners Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 8

Professionals
  • Investments
  • 184

  • Portfolio
  • 46

  • Exits
  • 105

Exits

HBM Partners General Information

Description

Founded in 2001, HBM Partners is a venture capital firm based in Zug, Switzerland. The firm prefers to invest in seed-stage, early-stage, later-stage, and growth-stage companies operating in healthcare sectors based in Europe, North America, and India.

Contact Information

Year Founded
2001
Investor Status
Actively Seeking New Investments
Trade Association
Swiss Private Equity & Corporate Finance (SWPE)
Primary Investor Type
Venture Capital
Other Investor Types
Asset Manager
Growth/Expansion
PE/Buyout
Primary Office
  • Bundesplatz 1
  • 6301 Zug
  • Switzerland
+41 043 000 00 00

HBM Partners Investments (184)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Research Instruments Group 10-Mar-2022 Buyout/LBO Distributors/Wholesale Generating Revenue
000000000000 07-Feb-2022 00000 00000 0000 Internet Retail Generating Revenue 000000000 0000 00.0
0000 (0000 0000000 01-Feb-2022 00000 00000 Drug Discovery Clinical Trials - Phase 1
00000000 11-Jan-2022 00000 00000 00000 Laboratory Services (Healthcare) Clinical Trials - General
0000000 0000000000 07-Dec-2021 00000 00000 00000 Drug Discovery Generating Revenue
0000 15-Nov-2021 0000 00000 Drug Discovery Generating Revenue
0000000 0000000000 11-Nov-2021 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2
00000 000000000000 11-Nov-2021 00000 00000 00000 Drug Discovery Startup
Antiva Biosciences 02-Nov-2021 Later Stage VC 0000 Drug Discovery Generating Revenue
Sphingotec 24-Sep-2021 Later Stage VC 00.000 Drug Discovery Generating Revenue 00000000 0000 00.0
You’re viewing 10 of 184 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HBM Partners Exits (105)

Company Name Exit Date Exit Type Exit Size
Complexa 09-Jun-2022 Out of Business
00 0000000 05-Nov-2021 000 00000
000 0000000 000000 28-Jun-2021 000000000000000000 00000
00000 0000 0000000 24-Jun-2021 000 00000
00000 18-Jun-2021 000 00000
000 10-Jun-2021 000000000000000000
00000000 000000000 30-Apr-2021 000 00000
000000000 00000000 19-Apr-2021 0000000000: 000000
Connect Biopharmaceuticals 19-Mar-2021 IPO 00000
Instil Bio 19-Mar-2021 IPO 00000
You’re viewing 10 of 105 exits. Get the full list »

HBM Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore HBM Partners‘s full profile, request access.

Request a free trial

HBM Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

HBM Partners Team (32)

Name Title Deals Funds Boards Office
Erwin Troxler Chief Financial Officer & Board Member 0 Zug, Switzerland
Cindy Chen Chief Operating Officer & Executive, Business Development, Risk and Compliance, HBM Partners Hong Kong Limited Zug, Switzerland
Steve Chen Managing Director and Investment Advisor, HBM Partners Hong Kong Limited Zug, Switzerland
Michael Buschle Ph.D Venture Partner Private Equity Zug, Switzerland
Miles Schofield Business Development, Risk and Compliance - Trading & Execution Public Equity Zug, Switzerland
You’re viewing 5 of 32 team members. Get the full list »

HBM Partners Co-Investors (317)

Name With Exits Lead Partner Series Industry
HBM Healthcare Investments 60 0 0 Series chart Industry bar
Cormorant Asset Management 00 0 0 Series chart Industry bar
RA Capital Management 00 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
RTW Investments 0 0 0 Series chart Industry bar
You’re viewing 5 of 317 co-investors. Get the full list »